小分子药物的γ-分泌酶抑制和调节的结构基础
Guanghui Yang1, Rui Zhou2, Xuefei Guo2
1Beijing Advanced Innovation Center for Structural Biology and Research Center for Biological Structure, Tsinghua-Peking Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China; State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.
Cell
|December 29, 2020
概括
对γ-分泌酶抑制剂 (GSI) 和调节剂 (GSM) 的结构洞察力揭示了它们如何向阿尔茨海默病和癌症途径. 了解这些机制对于开发下一代疗法至关重要.
科学领域:
- 生物化学
- 结构生物学
- 神经科学
背景情况:
- γ-分泌酶抑制剂 (GSI) 和调节剂 (GSM) 是阿尔茨海默病 (AD) 和癌症的有前途的治疗药物.
- GSI和GSM对γ-分泌酶的精确向机制在很大程度上仍未得到阐明.
研究的目的:
- 确定g-分泌酶抑制和调节的结构基础.
- 以指导新型基质选择性抑制剂的开发.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 解析人类γ-分泌酶的结构.
- 确定了与临床候选GSI (Semagacestat,Avagacestat) 结合的γ-分泌酶结构,一个过渡状态的模拟GSI (L685,458) 和一个GSM (E2012).
主要成果:
- GSIs与基质β链所占据的Presenilin 1 (PS1) 位点结合,从而阻碍基质的吸收.
- L685,458与PS1的催化酸盐残留物直接相互作用.
- E2012结合到一个全位,这表明其调节活动的机制.
结论:
- 结构数据显示GSI和GSM的绑定模式不同.
- 这些发现为设计具有更高选择性和有效性的下一代γ-分泌酶调节剂提供了基础.
相关概念视频
Targets for Drug Action: Overview
9.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.1K
GTPases and their Regulation
9.4K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
9.4K
Amplifying Signals via Enzymatic Cascade
15.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.5K
Antiepileptic Drugs: GABAergic Pathway Potentiators
962
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
962
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.4K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.4K
TGF - β Signaling Pathway
9.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.5K


